LivaNova (LIVN) Competitors $44.33 -2.34 (-5.01%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$44.31 -0.02 (-0.04%) As of 07/11/2025 05:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIVN vs. PEN, STVN, GKOS, BLCO, NARI, IRTC, TMDX, SLNO, INSP, and NVSTShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), and Envista (NVST). These companies are all part of the "medical equipment" industry. LivaNova vs. Its Competitors Penumbra Stevanato Group Glaukos Bausch + Lomb Inari Medical iRhythm Technologies TransMedics Group Soleno Therapeutics Inspire Medical Systems Envista Penumbra (NYSE:PEN) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends. Is PEN or LIVN more profitable? Penumbra has a net margin of 3.41% compared to LivaNova's net margin of -17.41%. LivaNova's return on equity of 13.67% beat Penumbra's return on equity.Company Net Margins Return on Equity Return on Assets Penumbra3.41% 11.14% 8.40% LivaNova -17.41%13.67%6.68% Which has more volatility and risk, PEN or LIVN? Penumbra has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Do institutionals & insiders have more ownership in PEN or LIVN? 88.9% of Penumbra shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 4.2% of Penumbra shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer PEN or LIVN? In the previous week, Penumbra had 6 more articles in the media than LivaNova. MarketBeat recorded 11 mentions for Penumbra and 5 mentions for LivaNova. LivaNova's average media sentiment score of 1.01 beat Penumbra's score of 0.81 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend PEN or LIVN? Penumbra currently has a consensus target price of $305.07, suggesting a potential upside of 28.52%. LivaNova has a consensus target price of $59.29, suggesting a potential upside of 33.74%. Given LivaNova's stronger consensus rating and higher probable upside, analysts plainly believe LivaNova is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, PEN or LIVN? LivaNova has higher revenue and earnings than Penumbra. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.19B7.70$14.01M$1.06223.93LivaNova$1.25B1.93$63.23M-$4.09-10.84 SummaryPenumbra and LivaNova tied by winning 8 of the 16 factors compared between the two stocks. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.54B$6.82B$5.60B$9.11BDividend YieldN/A1.25%5.24%4.02%P/E Ratio-10.8424.8927.9620.25Price / Sales1.9365.26430.8999.65Price / Cash11.0120.9237.4658.16Price / Book1.824.648.045.49Net Income$63.23M$174.76M$3.18B$250.27M7 Day Performance-3.90%-1.00%3.63%4.75%1 Month Performance-4.93%-1.49%4.04%7.64%1 Year Performance-13.81%4.27%29.55%16.34% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova3.1525 of 5 stars$44.33-5.0%$59.29+33.7%-15.4%$2.54B$1.25B-10.842,900Positive NewsPENPenumbra4.7811 of 5 stars$248.05-1.2%$302.40+21.9%+27.4%$9.72B$1.19B76.314,500Analyst ForecastInsider TradeSTVNStevanato Group1.3797 of 5 stars€24.23-1.5%N/A+20.1%€7.34B€1.19B47.515,521GKOSGlaukos4.3394 of 5 stars$101.69-1.7%$134.67+32.4%-15.9%$5.91B$383.48M0.00780BLCOBausch + Lomb3.091 of 5 stars$13.83-0.4%$15.54+12.4%-12.7%$4.91B$4.79B28.9213,500Analyst ForecastNARIInari Medical0.2696 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageIRTCiRhythm Technologies1.0415 of 5 stars$139.22-2.3%$138.60-0.4%+39.7%$4.55B$591.84M0.002,000TMDXTransMedics Group2.2111 of 5 stars$125.17-3.1%$127.33+1.7%-21.9%$4.37B$441.54M94.99210News CoveragePositive NewsAnalyst RevisionSLNOSoleno Therapeutics4.6215 of 5 stars$85.27-1.6%$107.10+25.6%+83.3%$4.37BN/A0.0030Trending NewsAnalyst ForecastINSPInspire Medical Systems4.9115 of 5 stars$127.11-1.1%$211.91+66.7%-3.8%$3.79B$802.80M59.211,246News CoveragePositive NewsAnalyst UpgradeNVSTEnvista3.2491 of 5 stars$19.66-3.6%$20.23+2.9%+20.7%$3.46B$2.51B28.7212,300Analyst Forecast Related Companies and Tools Related Companies PEN Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives NARI Alternatives IRTC Alternatives TMDX Alternatives SLNO Alternatives INSP Alternatives NVST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIVN) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIVN Stock Alerts